Literature DB >> 22273166

Use of, satisfaction with, and willingness to switch prescription and over-the-counter treatments for chronic urticaria: an online survey.

Donald E Stull1, Sonia Gavriel.   

Abstract

BACKGROUND: : Chronic urticaria (hives) affects a sizeable number of people worldwide, perhaps as much as 3%. It is often accompanied by angioedema. The negative effects of urticaria and angioedema, and any adverse effects of treatment, can result in significant patient burden.
OBJECTIVE: : To explore patients' use of, preferences for, and willingness to switch from prescription to over-the-counter (OTC) treatments for chronic urticaria. In addition, we compared treatment satisfaction with the treatment used most recently for their chronic urticaria.
METHODS: : Data were collected by an online survey using members of international consumer survey panels representative of the general populations in France and Germany. Panelists with urticaria were selected based on answers to screening questions. Respondents were asked, in their native language, questions about their typical course of treatment (prescription vs OTC), satisfaction with treatment, troublesomeness of their typical outbreak, whether their condition had improved or become worse over the past 12 months, and their willingness to try a new treatment if one became available. Descriptive analyses were performed on selected variables. Groups were compared using difference of means tests. Correlations and multiple regressions were performed to assess predictors of satisfaction with treatment and likelihood of switching treatment.
RESULTS: : The final study sample consisted of 405 patients. Patients who used prescription treatments were more satisfied and reported greater treatment benefits with their treatment than those using OTC treatments. Patients who felt that their condition had become worse over the past 12 months were more likely to consider switching treatments. Respondents who used Aerius (desloratadine) most recently for treating their symptoms reported greater satisfaction with treatment than did those who used other commonly used prescription treatments most recently.
CONCLUSIONS: : These results suggest that prescription treatments for chronic urticaria have a valuable place amongst the treatments offered for this very uncomfortable condition. Moreover, patients expressed preference for prescription treatments in large part because they felt that these treatments work.

Entities:  

Year:  2009        PMID: 22273166     DOI: 10.2165/11314870-000000000-00000

Source DB:  PubMed          Journal:  Patient        ISSN: 1178-1653            Impact factor:   3.883


  16 in total

1.  Management of urticaria.

Authors:  Samantha Walker; Aziz Sheikh
Journal:  Prim Care Respir J       Date:  2005-04-13

2.  Musculosketal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects.

Authors:  H Moldofsky; P Scarisbrick; R England; H Smythe
Journal:  Psychosom Med       Date:  1975 Jul-Aug       Impact factor: 4.312

3.  Prolongation of simple and choice reaction times in a double-blind comparison of twice-daily hydroxyzine versus terfenadine.

Authors:  D W Goetz; J M Jacobson; J E Murnane; M J Reid; D W Repperger; C Goodyear; M E Martin
Journal:  J Allergy Clin Immunol       Date:  1989-09       Impact factor: 10.793

4.  Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine.

Authors:  Laura Y McGirt; Kavitha Vasagar; Laura M Gober; Sarbjit S Saini; Lisa A Beck
Journal:  Arch Dermatol       Date:  2006-10

Review 5.  Medications and their effects on sleep.

Authors:  J F Pagel
Journal:  Prim Care       Date:  2005-06       Impact factor: 2.907

Review 6.  5. Allergy and the skin: eczema and chronic urticaria.

Authors:  Constance H Katelaris; Jane E Peake
Journal:  Med J Aust       Date:  2006-11-06       Impact factor: 7.738

Review 7.  Chronic urticaria: pathogenesis and treatment.

Authors:  Allen P Kaplan
Journal:  J Allergy Clin Immunol       Date:  2004-09       Impact factor: 10.793

8.  Seasonal allergic rhinitis and antihistamine effects on children's learning.

Authors:  E F Vuurman; L M van Veggel; M M Uiterwijk; D Leutner; J F O'Hanlon
Journal:  Ann Allergy       Date:  1993-08

9.  Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients.

Authors:  E Toubi; A Kessel; N Avshovich; E Bamberger; E Sabo; D Nusem; J Panasoff
Journal:  Allergy       Date:  2004-08       Impact factor: 13.146

Review 10.  Insomnia: epidemiology, characteristics, and consequences.

Authors:  Thomas Roth; Timothy Roehrs
Journal:  Clin Cornerstone       Date:  2003
View more
  2 in total

Review 1.  Safety of fexofenadine and other second-generation oral antihistamines before and after the removal of the prescription requirement in Italy and other European countries: A real-world evidence study and systematic review.

Authors:  Carla Carnovale; Vera Battini; Michele Gringeri; Marina Volonté; Maria Chiara Uboldi; Andrea Chiarenza; Giovanni Passalacqua
Journal:  World Allergy Organ J       Date:  2022-07-02       Impact factor: 5.516

Review 2.  Role of bilastine in the management of allergic rhinitis and urticaria: an Asia-Pacific consensus statement.

Authors:  Ralph Mösges; Dennis Lip Yen Lee; Jovilia Abong; Bella Siasoco; Steven Kw Chow; Jern-Lin Leong; Harvinder Singh; S Kuljit; Benjamin Campomanes
Journal:  Asia Pac Allergy       Date:  2016-01-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.